Co-infection with Mycobacterium tuberculosis and human immunodeficiency virus: an overview and motivation for systems approaches
- PMID: 23821533
- DOI: 10.1111/2049-632X.12060
Co-infection with Mycobacterium tuberculosis and human immunodeficiency virus: an overview and motivation for systems approaches
Abstract
Tuberculosis is a devastating disease that accounts for a high proportion of infectious disease morbidity and mortality worldwide. HIV-1 co-infection exacerbates tuberculosis. Enhanced understanding of the host-pathogen relationship in HIV-1 and Mycobacterium tuberculosis co-infection is required. While reductionist approaches have yielded many valuable insights into disease pathogenesis, systems approaches are required that develop data-driven models able to predict emergent properties of this complex co-infection system in order to develop novel therapeutic approaches and to improve diagnostics. Here, we provide a pathogenesis-focused overview of HIV-TB co-infection followed by an introduction to systems approaches and concrete examples of how such approaches are useful.
Keywords: HIV-1; Systems biology; complex systems; emergent properties; host-pathogen interface; model integration.
© 2013 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.
Similar articles
-
Recent progress in understanding immune activation in the pathogenesis in HIV-tuberculosis co-infection.Curr Opin HIV AIDS. 2018 Nov;13(6):455-461. doi: 10.1097/COH.0000000000000501. Curr Opin HIV AIDS. 2018. PMID: 30286038 Review.
-
Productive HIV-1 infection is enriched in CD4(-)CD8(-) double negative (DN) T cells at pleural sites of dual infection with HIV and Mycobacterium tuberculosis.Arch Virol. 2016 Jan;161(1):181-7. doi: 10.1007/s00705-015-2640-7. Epub 2015 Oct 23. Arch Virol. 2016. PMID: 26497177
-
Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis.Curr Opin HIV AIDS. 2012 May;7(3):268-75. doi: 10.1097/COH.0b013e3283524e32. Curr Opin HIV AIDS. 2012. PMID: 22495739 Review.
-
Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection.Front Immunol. 2021 Mar 26;12:647728. doi: 10.3389/fimmu.2021.647728. eCollection 2021. Front Immunol. 2021. PMID: 33841429 Free PMC article.
-
Changing concepts of "latent tuberculosis infection" in patients living with HIV infection.Clin Dev Immunol. 2011;2011:980594. doi: 10.1155/2011/980594. Epub 2010 Sep 26. Clin Dev Immunol. 2011. PMID: 20936108 Free PMC article.
Cited by
-
Epidemiological features and temporal trends of the co-infection between HIV and tuberculosis, 1990-2021: findings from the Global Burden of Disease Study 2021.Infect Dis Poverty. 2024 Aug 16;13(1):59. doi: 10.1186/s40249-024-01230-3. Infect Dis Poverty. 2024. PMID: 39152514 Free PMC article.
-
Colonization with Helicobacter is concomitant with modified gut microbiota and drastic failure of the immune control of Mycobacterium tuberculosis.Mucosal Immunol. 2017 Sep;10(5):1178-1189. doi: 10.1038/mi.2016.140. Epub 2017 Feb 1. Mucosal Immunol. 2017. PMID: 28145441
-
Pulmonary coinfection of Mycobacterium tuberculosis and Tropheryma whipplei: a case report.J Med Case Rep. 2021 Jul 9;15(1):359. doi: 10.1186/s13256-021-02899-y. J Med Case Rep. 2021. PMID: 34243811 Free PMC article.
-
Tuberculosis exposure, infection and disease in children: a systematic diagnostic approach.Pneumonia (Nathan). 2016 Nov 24;8:23. doi: 10.1186/s41479-016-0023-9. eCollection 2016. Pneumonia (Nathan). 2016. PMID: 28702302 Free PMC article. Review.
-
ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo.J Clin Invest. 2016 Jun 1;126(6):2109-22. doi: 10.1172/JCI84978. Epub 2016 Apr 25. J Clin Invest. 2016. PMID: 27111234 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
